IP Library Granted Patent US 8,487,078
Granted Patent B2
US 8,487,078 · App. 13/252,679 · Granted Jul 16, 2013

Kinase and phosphatase assays

Inventors: Tony Klink (Madison, WI); Jane Beebe (Elkhorn, WI); David Lasky (Madison, WI); Karen Kleman-Leyer (Madison, WI); Richard Somberg (Madison, WI)
Assignee: Life Technologies Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,487,078
App. No.
13/252,679
Granted
Jul 16, 2013
Kind
B2
Abstract

Compositions, methods, and kits for detecting and monitoring kinase, phosphatase and protein post-translational modification activity are described. The compositions typically include a peptide, a detectable moiety, and a protease cleavage site. Modification of a peptide by a kinase, phosphatase or other protein post-translational modification alters the proteolytic sensitivity of the peptide, resulting in a change of a detectable property of the composition. Panel assays for determining substrates or modulators of kinase, phosphatase or other protein post-translational modification activity are also described.

Claims (40)

1. A composition of matter comprising:

(a) a peptide having a length up to fifty amino acids, the peptide comprising

EEEYIQI (SEQ ID NO: 18) or EEEEYIQIVK (SEQ ID NO: 19); and

(b) a first detectable moiety associated with the peptide.

2. The composition of claim 1 , wherein the first detectable moiety is covalently linked to the peptide.

3. The composition of claim 1 , wherein the peptide comprises a protease cleavage site.

4. The composition of claim 3 , wherein the protease cleavage site is selected from the group consisting of a chymotrypsin protease cleavage site, a caspase 3 protease cleavage site, a cathepsin G protease cleavage site, a trypsin protease cleavage site, an elastase protease cleavage site, an endoproteinase Asp-N protease cleavage site, and an endoproteinase Glu-N protease cleavage site.

5. The composition of claim 1 , wherein the peptide has a length selected from the group consisting of from 8 to 50 amino acids, from 8 to 25 amino acids and from 8 to 15 amino acids.

6. The composition of claim 1 , further comprising a second detectable moiety associated with the peptide.

7. The composition of claim 1 , wherein the composition exhibits an optical property, a magnetic property, or a radioactive property.

8. The composition of claim 6 , wherein the first or second detectable moieties are selected from the group consisting of 5-FAM, 6-FAM, 7-hydroxycoumarin-3-carboxamide, 6-chloro-7-hydroxycoumarin-3-carboxamide, fluorescein-5-isothiocyanate, dichlorotriazinylaminofluorescein, tetramethylrhodamine-5-isothiocyanate, tetramethylrhodamine-6-isothiocyanate, succinimidyl ester of 5-carboxyfluorescein, succinimidyl ester of 6-carboxyfluorescein, 5-carboxytetramethylrhodamine, 6-carboxymethylrhodamine, fluorescein maleimide, and 7-amino-4-methylcoumarin-3-acetic acid.

9. The composition of claim 6 , wherein the first detectable moiety, the second detectable moiety or the first and second detectable moiety is a member of a specific binding pair.

10. The composition of claim 6 , wherein the first detectable moiety and the second detectable probe moiety form a dark quenching RET pair or a FRET pair.

11. The composition of claim 6 , wherein the first detectable moiety is 7-hydroxycoumarin-3-carboxamide and the second detectable moiety is 5-FAM.

12. The composition of claim 6 , wherein the first or second detectable probe moiety is covalently linked to the peptide via a linker (L).

13. A method for identifying a modulator of activity of a tyrosine kinase, comprising:

(a) forming a mixture of a protein kinase, a composition of claim 1 , and a test compound;

(b) contacting the mixture with a protease to form a protease mixture; and

(c) comparing a measurable property in the protease mixture to the measurable property in a control mixture, wherein the test compound is identified as a modulator of activity of the kinase if the measurable property in the protease mixture is different from the measurable property in the control mixture.

14. An article of manufacture comprising:

(a) packaging matter; and

(b) a composition of matter according to claim 1 associated with the packaging material; and

(c) at least one member selected from the group consisting of a tyrosine protein kinase, a tyrosine protein phosphatase, a protease and ATP.

15. A composition of matter comprising:

(a) a peptide having a length from five to fifty amino acids, the peptide comprising EEYIQ (SEQ ID NO: 17); and

(b) a first detectable moiety covalently linked to the peptide, wherein the first detectable moiety is selected from the group consisting of 5-FAM, 6-FAM, 7-hydroxycoumarin-3-carboxamide, 6-chloro-7-hydroxycoumarin-3-carboxamide, fluorescein-5-isothiocyanate, dichlorotriazinylaminofluorescein, tetramethylrhodamine-5-isothiocyanate, tetramethylrhodamine-6-isothiocyanate, succinimidyl ester of 5-carboxyfluorescein, succinimidyl ester of 6-carboxyfluorescein, 5-carboxytetramethylrhodamine, 6-carboxymethylrhodamine, fluorescein maleimide, and 7-amino-4-methylcoumarin-3-acetic acid.

16. The composition of claim 15 , wherein the peptide comprises a protease cleavage site.

17. The composition of claim 16 , wherein the protease cleavage site is selected from the group consisting of a chymotrypsin protease cleavage site, a caspase 3 protease cleavage site, a cathepsin G protease cleavage site, a trypsin protease cleavage site, an elastase protease cleavage site, an endoproteinase Asp-N protease cleavage site, and an endoproteinase Glu-N protease cleavage site.

18. The composition of claim 15 , wherein the peptide has a length selected from the group consisting of from 8 to 50 amino acids, from 8 to 25 amino acids and from 8 to 15 amino acids.

19. The composition of claim 15 , wherein the composition further comprises a second detectable moiety.

20. The composition of claim 19 , wherein the first detectable moiety and the second detectable probe moiety form a dark quenching RET pair or a FRET pair.

21. The composition of claim 19 , wherein the first or second detectable probe moiety is covalently linked to the peptide via a linker (L).

22. A method for identifying a modulator of activity of a tyrosine kinase, comprising:

(a) forming a mixture of a protein kinase, a composition of claim 15 , and a test compound;

(b) contacting the mixture with a protease to form a protease mixture; and

(c) comparing a measurable property in the protease mixture to the measurable property in a control mixture, wherein the test compound is identified as a modulator of activity of the kinase if the measurable property in the protease mixture is different from the measurable property in the control mixture.

23. An article of manufacture comprising:

(a) packaging matter; and

(b) a composition of matter according to claim 15 associated with the packaging material; and

(c) at least one member selected from the group consisting of a protein kinase, a protein phosphatase, a protease and ATP.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2013
From: KLINK, TONY; BEEBE, JANE; LASKY, DAVID; KLEMAN-LEYER, KAREN; SOMBERG, RICHARD
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 031721/0568 →
Continuity (8)
Continuation 12728926 · Mar 22, 2010
Continuation 11485957 · Jul 14, 2006
Continuation In Part 10903529 · Jul 29, 2004
Continuation In Part 10937042 · Sep 9, 2004
Continuation In Part 10903529 · Jul 29, 2004
Provisional Application 60699174 · Jul 14, 2005
Provisional Application 60490771 · Jul 29, 2003
Related Publication 20120083427A1 · Apr 5, 2012